A Leukocyte Score to Improve Clinical Outcome Predictions in Bacteremic Pneumococcal Pneumonia in Adults

被引:14
作者
Blot, Mathieu [1 ]
Croisier, Delphine [1 ]
Pechinot, Andre [2 ,3 ]
Vagner, Ameline [4 ]
Putot, Alain [1 ]
Fillion, Aurelie [1 ]
Baudouin, Nicolas [4 ]
Quenot, Jean-Pierre [5 ,6 ,7 ]
Charles, Pierre-Emmanuel [5 ]
Bonniaud, Philippe [4 ]
Chavanet, Pascal [1 ]
Piroth, Lionel [1 ]
机构
[1] Dept Infectiol, Bourgogne, France
[2] Lab Bacteriol Plateau Tech Biol, Bourgogne, France
[3] Observ Reg Pneumocoque, Bourgogne, France
[4] Ctr Hosp Univ, Serv Pneumol & Reanimat Resp, Dijon, France
[5] Ctr Hosp Univ, Serv Reanimat Med, Dijon, France
[6] Ctr Hosp Univ, Ctr Invest Clin Epidemiol Clin Essais Clin, Dijon, France
[7] Inst Natl Sante & Rech Med, Dijon, France
关键词
bacteremia; leukocyte; mortality; pneumonia; Streptococcus pneumonia;
D O I
10.1093/ofid/ofu075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Bacteremic pneumococcal pneumonia (BPP) is associated with high and early mortality. A simple procedure to predict mortality is crucial. Methods. All adult patients with BPP admitted from 2005 through 2013 to the University Hospital of Dijon, France, were enrolled to study 30-day mortality and associated factors, particularly leukocyte counts. A simple leukocyte score was created by adding 1 point each for neutropenia (<1500 cells/mm(3)), lymphopenia (<400), and monocytopenia (<200). Results. One hundred and ninety-two adult patients (mean age, 69 years; standard deviation [SD], 19 years) who had developed and were hospitalized for BPP (58% community-acquired) were included. The 30-day crude mortality rate was 21%. The mean Pneumonia Severity Index score was high at 127.3 (SD = 41.3). Among the 182 patients who had a white blood cell count, 34 (19%) had a high leukocyte score (>= 2). Multivariate analysis revealed that mortality was significantly associated with a high leukocyte score (odds ratio, 6.28; 95% confidence interval, 2.35-16.78), a high respiratory rate, a low serum bicarbonate level, and an altered mental status (all P < .05). The leukocyte score was not significantly dependent on the previous state of immunosuppression, alcoholism, or viral coinfection, but it did correlate with an acute respiratory distress syndrome and a low serum bicarbonate level. Conclusions. This new leukocyte score, in combination with the well known predictive factors, seems of interest in predicting the risk of death in BPP. A high score correlated with organ dysfunction and probably reflects the level of immunoparalysis. Its predictive value has to be confirmed in other cohorts.
引用
收藏
页数:10
相关论文
共 40 条
[1]  
Johansson N., Kalin M., Tiveljung-Lindell A., Et al., Etiology of community- acquired pneumonia:ncreased microbiological yield with new diagnostic methods, Clin Infect Dis, 50, pp. 202-209, (2010)
[2]  
Polverino E., Torres A., Menendez R., Et al., Microbial aetiology of healthcare associated pneumonian Spain: a prospective, multicentre, casecontrol study, Thorax, 68, pp. 1007-1014, (2013)
[3]  
Pereira J.M., Teixeira-Pinto A., Basilio C., Et al., Can we predict pneumococcal bacteremian patients with severe community-acquired pneumonia, J Crit Care, 28, pp. 970-974, (2013)
[4]  
Kang C.I., Song J.H., Kim S.H., Et al., Risk factors and pathogenic significance of bacteremic pneumonian adult patients with communityacquired pneumococcal pneumonia, J Infect, 66, pp. 34-40, (2013)
[5]  
Austrian R., Gold J., Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia, Ann Intern Med, 60, pp. 759-776, (1964)
[6]  
Garcia-Vidal C., Fernandez-Sabe N., Carratala J., Et al., Early mortalityn patients with community-acquired pneumonia: causes and risk factors, Eur Respir J, 32, pp. 733-739, (2008)
[7]  
Berjohn C.M., Fishman N.O., Joffe M.M., Et al., Treatment and outcomes for patients with bacteremic pneumococcal pneumonia, Medicine (Baltimore), 87, pp. 160-166, (2008)
[8]  
Lujan M., Gallego M., Fontanals D., Et al., Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality, Crit Care Med, 32, pp. 625-631, (2004)
[9]  
Menendez R., Torres A., Zalacain R., Et al., Risk factors of treatment failuren community acquired pneumonia:mplications for disease outcome, Thorax, 59, pp. 960-965, (2004)
[10]  
Khanafer N., Sicot N., Vanhems P., Et al., Severe leukopenian Staphylococcus aureus-necrotizing, community-acquired pneumonia: risk factors andmpact on survival, BMC Infect Dis, 13, (2013)